BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
Business News on Ranbaxy Laboratories
USFDA bans two Indian plants on GMP violations
9.28 pm | 26 Sep 2014 | Source: CNBC-TV18
The USFDA has served import alerts to Canadian drug company Apotex Research’s manufacturing facility in Bangalore and Indian firm Micro Labs manufac...
Quick Links for Ranbaxy Laboratories
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.